请输入关键字
请输入关键字
订购
*国家
中国
美国
中国香港
中国澳门
中国台湾
阿尔巴尼亚
阿尔及利亚
阿根廷
阿拉伯联合酋长国
阿鲁巴
阿曼
阿塞拜疆
阿森松岛
埃及
埃塞俄比亚
爱尔兰
爱沙尼亚
安道尔
安哥拉
安圭拉
安提瓜和巴布达
奥地利
奥兰群岛
澳大利亚
巴巴多斯
巴布亚新几内亚
巴哈马
巴基斯坦
巴拉圭
巴勒斯坦领土
巴林
巴拿马
巴西
白俄罗斯
百慕大
保加利亚
北马里亚纳群岛
贝宁
比利时
冰岛
波多黎各
波兰
波斯尼亚和黑塞哥维那
玻利维亚
伯利兹
博茨瓦纳
不丹
布基纳法索
布隆迪
朝鲜
赤道几内亚
丹麦
德国
迪戈加西亚岛
东帝汶
多哥
多米尼加共和国
多米尼克
俄罗斯
厄瓜多尔
厄立特里亚
法国
法罗群岛
法属波利尼西亚
法属圭亚那
法属南部领地
梵蒂冈
菲律宾
斐济
芬兰
佛得角
福克兰群岛
冈比亚
刚果(布)
刚果(金)
哥伦比亚
哥斯达黎加
格恩西岛
格林纳达
格陵兰
格鲁吉亚
古巴
瓜德罗普
关岛
圭亚那
哈萨克斯坦
海地
韩国
荷兰
荷属加勒比区
荷属圣马丁
黑山
洪都拉斯
基里巴斯
吉布提
吉尔吉斯斯坦
几内亚
几内亚比绍
加拿大
加纳
加纳利群岛
加蓬
柬埔寨
捷克
津巴布韦
喀麦隆
卡塔尔
开曼群岛
科科斯(基林)群岛
科摩罗
科索沃
科特迪瓦
科威特
克罗地亚
肯尼亚
库克群岛
库拉索
拉脱维亚
莱索托
老挝
黎巴嫩
立陶宛
利比里亚
利比亚
联合国
列支敦士登
留尼汪
卢森堡
卢旺达
罗马尼亚
马达加斯加
马恩岛
马尔代夫
马耳他
马拉维
马来西亚
马里
马其顿
马绍尔群岛
马提尼克
马约特
毛里求斯
毛里塔尼亚
美国本土外小岛屿
美属萨摩亚
美属维尔京群岛
蒙古
蒙特塞拉特
孟加拉国
秘鲁
密克罗尼西亚
缅甸
摩尔多瓦
摩洛哥
摩纳哥
莫桑比克
墨西哥
纳米比亚
南非
南极洲
南乔治亚和南桑威奇群岛
南苏丹
瑙鲁
尼加拉瓜
尼泊尔
尼日尔
尼日利亚
纽埃
挪威
诺福克岛
帕劳
皮特凯恩群岛
葡萄牙
日本
瑞典
瑞士
萨尔瓦多
萨摩亚
塞尔维亚
塞拉利昂
塞内加尔
塞浦路斯
塞舌尔
沙特阿拉伯
圣巴泰勒米
圣诞岛
圣多美和普林西比
圣赫勒拿
圣基茨和尼维斯
圣卢西亚
圣马丁岛
圣马力诺
圣皮埃尔和密克隆群岛
圣文森特和格林纳丁斯
斯里兰卡
斯洛伐克
斯洛文尼亚
斯瓦尔巴和扬马延
斯威士兰
苏丹
苏里南
所罗门群岛
索马里
塔吉克斯坦
泰国
坦桑尼亚
汤加
特克斯和凯科斯群岛
特里斯坦-达库尼亚群岛
特立尼达和多巴哥
突尼斯
图瓦卢
土耳其
土库曼斯坦
托克劳
瓦利斯和富图纳
瓦努阿图
危地马拉
委内瑞拉
文莱
乌干达
乌克兰
乌拉圭
乌兹别克斯坦
希腊
西班牙
西撒哈拉
新加坡
新喀里多尼亚
新西兰
匈牙利
休达及梅利利亚
叙利亚
牙买加
亚美尼亚
也门
伊拉克
伊朗
以色列
意大利
印度
印度尼西亚
英国
英属维尔京群岛
英属印度洋领地
约旦
越南
赞比亚
泽西岛
乍得
直布罗陀
智利
中非共和国
*省份
*城市
*姓名
*电话
*单位
*职位
*邮箱
*请输入验证码
*验证码
B-hTL1A/hDR3 mice
Strain Name

C57BL/6N-Tnfsf15tm2(TNFSF15)Bcgen 

Tnfrsf25tm3(TNFRSF25)Bcgen/Bcgen 

Common Name  B-hTL1A/hDR3 mice
Background C57BL/6N Catalog Number 113082
Aliases 

TL1, TL1A, TNLG1B, VEGI, VEGI192A; 

APO-3, DDR3, DR3, GEF720, LARD, PLEKHG5, TNFRSF12, TR3, TRAMP, WSL-1, WSL-LR

NCBI Gene ID
9966, 8718
Description

  • TL1A binds to death receptor 3 (DR3) to provide stimulatory signals for downstream signaling pathways, thereby regulating the proliferation, activation, apoptosis of effector cells, and the production of cytokines and chemokines. Soluble decoy receptor 3 (DcR3) may neutralize the effects of sTL1A/DR3. In addition, DcR3 can inhibit apoptosis, reduce inflammation, and prevent tissue damage by neutralizing LIGHT and FasL. 
  • The genome of the mouse Tl1a gene encoding the extracellular domain was replaced with its human TL1A counterpart in B-hTL1A/hDR3 mice. The genome of the mouse Dr3 gene encoding the full-length protein was replaced with human DR3 counterpart in B-hTL1A/hDR3 mice.
  • Mouse Tl1a and Dr3 mRNA were detectable in wild-type C57BL/6N mice, and human TL1A and DR3 mRNA was exclusively detectable in homozygous B-hTL1A/hDR3 mice. Human TL1A protein was detectable in homozygous B-hTL1A/hDR3 mice. mDR3 was detectable on Treg cells of wild-type mice, hDR3 was exclusively detectable on Treg cells of homozygous B-hTL1A/hDR3 mice. 
  • Activation of DR3 signaling pathway increased the expansion of Treg cells in wild-type C57BL/6N mice and homozygous B-hTL1A/hDR3 mice. 
  • Application: This product is used for pharmacodynamics and safety evaluation of  drugs.

Targeting strategy

Gene targeting strategy for B-hTL1A/hDR3 mice. 

The exons 1-4 of mouse Tl1a gene that encode extracellular domain were replaced by human counterparts in B-hTL1A/hDR3 mice. The genomic region of mouse Tl1a gene that encodes transmembrane domain and cytoplasmic portion was retained. The promoter, 5’UTR and 3’UTR region of the mouse gene were also retained. The chimeric TL1A expression was driven by endogenous mouse Tl1a promoter, while mouse Tl1a gene transcription and translation will be disrupted. 

The exons 1-10 of mouse Dr3 gene that encode the whole molecule (ATG to STOP codon), including promoter, 5’UTR and 3’UTR were replaced by human counterparts in B-hTL1A/hDR3 mice. The human DR3 expression was driven by human DR3 promoter, while mouse Dr3 gene transcription and translation will be disrupted.

mRNA expression analysis

from clipboard

Strain specific analysis of TL1A and DR3 mRNA expression in wild-type C57BL/6N mice and homozygous B-hTL1A/hDR3 mice by RT-PCR. Spleen, lung and colon RNA were isolated from wild-type C57BL/6N mice (+/+) and homozygous B-hTL1A/hDR3 mice (H/H,H/H). Mouse Tl1a and Dr3 mRNA were detectable in wild-type C57BL/6N mice. Human TL1A and DR3 mRNA was exclusively detectable in homozygous B-hTL1A/hDR3 mice, but not in wild-type C57BL/6N mice. 

Protein expression analysis

from clipboard

Strain specific TL1A expression analysis in homozygous B-hTL1A/hDR3 mice by ELISA. Bone marrow-derived dendritic cells were isolated from wild-type C57BL/6N mice (+/+) and homozygous B-hTL1A/hDR3 mice (H/H,H/H) and stimulated with 1 μg/mL LPS in vitro for 24 h, then cell supernatants were collected and analyzed by ELISA (anti-human TL1A ELISA kit: R&D, DY1319-05). Human TL1A was exclusively detectable in homozygous B-hTL1A/hDR3 mice but not in wild-type C57BL/6N mice.

Protein expression analysis in spleen

from clipboard

Strain specific DR3 expression analysis in homozygous B-hTL1A/hDR3 mice by flow cytometry. Splenocytes were collected from wild-type C57BL/6N mice (+/+) and homozygous B-hTL1A/hDR3 mice (H/H,H/H), and analyzed by flow cytometry with anti-mouse DR3 antibody (Biolegend,144407) and anti-human DR3 antibody (Biolegend, 307105). mDR3 was detectable on Treg cells of wild-type C57BL/6N mice, hDR3 was exclusively detectable on Treg cells of homozygous B-hTL1A/hDR3 mice. 

Protein expression analysis in blood

from clipboard

Strain specific DR3 expression analysis in homozygous B-hTL1A/hDR3 mice by flow cytometry. Blood were collected from wild-type C57BL/6N mice (+/+) and homozygous B-hTL1A/hDR3 mice (H/H,H/H), and analyzed by flow cytometry with anti-mouse DR3 antibody (Biolegend,144407) and anti-human DR3 antibody (Biolegend, 307105). mDR3 was detectable on Treg cells of wild-type C57BL/6N mice, hDR3 was exclusively detectable on Treg cells of homozygous B-hTL1A/hDR3 mice. 

Human DR3 antibody binding assay

from clipboard

Anti-human DR3 antibody binding assessment in homozygous B-hTL1A/hDR3 mice by flow cytometry. Splenocytes and blood were collected from wild-type C57BL/6N mice (+/+) and homozygous B-hTL1A/hDR3 mice (H/H,H/H), and analyzed by flow cytometry with anti-human DR3 antibody Ab1, which is offered by the client. Ab1 can bind Treg cells of homozygous B-hTL1A/hDR3 mice. 

Functional analysis

from clipboard

Activation of DR3 signaling pathway increased the expansion of Treg cells in wild-type C57BL/6N mice and homozygous B-hTL1A/hDR3 mice. Wild-type C57BL/6N mice (+/+) and homozygous B-hTL1A/hDR3 mice (H/H,H/H) were given single intraperitoneal injection of DPBS, anti-mDR3 and anti-hDR3 antibodies on day 0, splenocytes and blood cells were collected on day 4 for flow analysis. The agonistic anti-mouse DR3 antibody Ab2 expanded Treg cell populations in wild-type C57BL/6N mice, and the agonistic anti-human DR3 antibody Ab3 increased Treg cells in homozygous B-hTL1A/hDR3 mice. These results contribute to a deeper understanding of DR3 activation in Treg cells modulation. 
Note: This experiment was conducted by the client using B-hTL1A/hDR3 mice.